Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity

Acute myeloid leukemia (AML) is an aggressive blood cancer where immature stem cells in the bone marrow multiply rapidly, disrupting blood cell production and leading to infections, anemia, and bleeding [...]

Saved in:
Bibliographic Details
Main Author: Deepesh Kumar Verma
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Proceedings
Subjects:
Online Access:https://www.mdpi.com/2504-3900/100/1/12
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850259770417610752
author Deepesh Kumar Verma
author_facet Deepesh Kumar Verma
author_sort Deepesh Kumar Verma
collection DOAJ
description Acute myeloid leukemia (AML) is an aggressive blood cancer where immature stem cells in the bone marrow multiply rapidly, disrupting blood cell production and leading to infections, anemia, and bleeding [...]
format Article
id doaj-art-5ef81bc0bb44440b984edf43e5702a6f
institution OA Journals
issn 2504-3900
language English
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Proceedings
spelling doaj-art-5ef81bc0bb44440b984edf43e5702a6f2025-08-20T01:55:48ZengMDPI AGProceedings2504-39002024-03-0110011210.3390/proceedings2024100012Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 BioactivityDeepesh Kumar Verma0ExcelR Solutions, Bangalore 560068, Karnataka, IndiaAcute myeloid leukemia (AML) is an aggressive blood cancer where immature stem cells in the bone marrow multiply rapidly, disrupting blood cell production and leading to infections, anemia, and bleeding [...]https://www.mdpi.com/2504-3900/100/1/12acute myeloid leukemia (AML)blood cancerRUNX1machine learningmutationscomputational drug discovery
spellingShingle Deepesh Kumar Verma
Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
Proceedings
acute myeloid leukemia (AML)
blood cancer
RUNX1
machine learning
mutations
computational drug discovery
title Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
title_full Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
title_fullStr Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
title_full_unstemmed Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
title_short Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
title_sort machine learning strategies for drug discovery in aml focus on runx1 bioactivity
topic acute myeloid leukemia (AML)
blood cancer
RUNX1
machine learning
mutations
computational drug discovery
url https://www.mdpi.com/2504-3900/100/1/12
work_keys_str_mv AT deepeshkumarverma machinelearningstrategiesfordrugdiscoveryinamlfocusonrunx1bioactivity